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Abstract
Fracture healing and distraction osteogenesis have important applications in orthopedic,
maxillofacial, and periodontal treatment. In this review, the cellular and molecular mechanisms
that regulate fracture repair are contrasted with bone regeneration that occurs during distraction
osteogenesis. While both processes have many common features, unique differences are observed
in the temporal appearance and expression of specific molecular factors that regulate each. The
relative importance of inflammatory cytokines in normal and diabetic healing, the transforming
growth factor beta superfamily of bone morphogenetic mediators, and the process of angiogenesis
are discussed as they relate to bone repair. A complete summary of biological activities and
functions of various bioactive factors may be found at COPE (Cytokines & Cells Online
Pathfinder Encyclopedia), http://www.copewithcytokines.de/cope.cgi.
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Introduction
Bone has a substantial capacity for repair and regeneration in response to injury or surgical
treatment. Both processes involve a complex integration of cells, growth factors, and the
extracellular matrix. Repair simply restores the continuity of the injured tissues, without
necessarily increasing bone volume. Regeneration, in contrast, involves the differentiation of
new cells and the formation of new bone tissue that results in an overall increase in volume
of new skeletal tissues.
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Fracture healing is a multistage repair process that involves complex yet well-orchestrated
steps that are initiated in response to injury, resulting eventually in the repair and restoration
of function. Distraction osteogenesis, in contrast, is a controlled surgical procedure that
initiates a regenerative process and uses mechanical strain to enhance the biological
responses of the injured tissues to create new bone. This surgical model is used to bridge gap
defects such as non-healing fractures, to treat disease conditions such as osteomyelitis,
where there has been a net destruction of the bone tissues, to augment the alveolar bone
around lost teeth, and to correct congenital skeletal deformities where there is a deficiency in
the original structure of the skeleton (Tay et al., 1998). Both biological processes are
controlled by complex molecular mechanisms that involve local and systemic factors that
interact with many cell types that are recruited to the injury or surgical site from the
surrounding tissues and circulation. Ongoing research has improved our understanding of
the molecular mechanisms involved with fracture healing and distraction osteogenesis. The
aim of this review is to characterize the cellular events that contribute to the healing process
and to describe the complexity of signaling pathways and molecules involved. Fracture
healing and distraction osteogenesis are presented to contrast two different mechanisms of
bone repair and regeneration.
Fracture Healing
Fracture repair recapitulates the pathway of normal embryonic development with the
coordinated participation of several cell types originating from the cortex, periosteum,
surrounding soft tissue, and bone marrow space (Ferguson et al., 1999; Gerstenfeld et al.,
2003b). The cellular and molecular processes of fracture healing are summarized in Tables 1
and 2.
The majority of fractures heal by the combination of both intramembranous and
endochondral ossification. Endochondral bone formation usually occurs external to the
periosteum in regions that are mechanically less stable and immediately adjacent to the
fracture site, whereas intramembranous ossification occurs internal to the periosteum at the
proximal and distal edges of the callus and forms hard callus (Dimitriou et al., 2005). It is
the eventual bridging of hard callus areas across the central fracture gap that provides the
initial stabilization and regaining of biomechanical function (Gerstenfeld et al., 2006). The
repair process itself is comprised of four overlapping phases, initiated by an immediate
inflammatory response that leads to the recruitment of mesenchymal stem cells and
subsequent differentiation into chondrocytes that produce cartilage and osteoblasts, which
form bone. After cartilage matrix is produced, it mineralizes, and a transition from
mineralized cartilage to bone occurs, initiated by the resorption of mineralized cartilage.
Primary bone formation is followed by remodeling, in which the initial bony callus is
reshaped by secondary bone formation and resorption to restore the anatomical structure that
supports mechanical loads (Gerstenfeld et al., 2003b). The biological processes taking place
during each of these stages are tightly regulated by signaling molecules that can be
categorized into three groups: (1) pro-inflammatory cytokines, (2) transforming growth
factor-beta superfamily (TGF-β) members, and (3) angiogenic factors. Each of these groups
of cytokines and morphogens has biological activities that promote overlapping biological
processes and orchestrate interactions between differing cell populations. As an example,
mesenchymal stem cells differentiate into both more specialized cells that make up the
effects of each other's activities (Peng et al., 2005).
The Role of Pro-inflammatory Cytokines in Fracture Repair
Inflammatory cytokines involved in fracture repair are believed to play a role in initiating
the repair cascade following injury. These cytokines are produced and function immediately
after injury for a limited time period. At a mid-stage in healing, some of the inflammatory
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cytokines are up-regulated, so osteoclastogenesis is stimulated to remove mineralized
cartilage, and others are induced at a later stage during bone remodeling.
Interleukins-1 and -6 (IL-1 and IL-6) and TNF-α have been shown to play a role in initiating
the repair cascade. They induce a downstream response to injury by recruiting other
inflammatory cells, enhancing extracellular matrix synthesis, and stimulating angiogenesis
(Kon et al., 2001). They are secreted at the injury site by macrophages, inflammatory cells,
and cells of mesenchymal origin. Their expression peaks within the first 24 hrs, then
declines rapidly to nearly undetectable levels by day 3 (Kon et al., 2001; Cho et al., 2002).
The expression of IL-1 and IL-6 rises again in association with bone remodeling during
secondary bone formation, whereas the expression of TNF-α rises in association with
mineralized cartilage resorption by the end of the endochondral phase of fracture repair
(Gerstenfeld et al., 2003a). In addition to stimulating osteoclast function, TNF-α promotes
the recruitment of mesenchymal stem cells and induces apoptosis of hypertrophic
chondrocytes during endochondral bone formation. Its absence delays the resorption of
mineralized cartilage and, consequently, prevents the formation of new bone. In situations
where TNF-α is over-expressed, such as diabetic healing, there is premature cartilage
removal that is associated with deficient bone formation and healing (Kayal et al., 2007).
The expression of RANKL and OPG (two members of the TNF-α superfamily), as well as
macrophage colony-stimulating factor (MCSF), which are key regulatory factors in
osteoclastogenesis, increases after initial injury as well as during the period of mineralized
cartilage resorption. During the phase of secondary bone formation and bone remodeling,
RANKL, OPG, and MCSF showed expression levels diminished from those seen during
cartilage resorption. In contrast, IL-1 and IL-6 expression rose during late remodeling
(Gerstenfeld et al., 2003b).
Pro-inflammatory Cytokines and Impaired Diabetic Fracture Healing
Diabetes causes diminished bone formation and increases the risk of fracture (Verhaeghe et
al., 1990; Vestergaard, 2007). Moreover, fracture healing is impaired in diabetic humans and
in animal models (Loder, 1988; Macey et al., 1989). There are likely to be multiple
mechanisms through which diabetes may affect bone, including the expression of genes that
regulate osteoblast differentiation and the expression of growth factors that promote bone
formation (Kawaguchi et al., 1994; Lu et al., 2003). To gain insight into how diabetes
affects fracture healing, investigators have carried out experiments in a type 1 diabetic
model, focusing on the impact of diabetes on the transition from cartilage to bone (Kayal et
al., 2007). There was relatively little difference in the initial amount of callus formed.
However, diabetes caused an increase in mRNA levels of TNF-α, MCSF, and RANKL. The
increase in these cytokines was accompanied by a similar increase in osteoclast numbers and
a more rapid degradation of cartilage. The greater loss of cartilage also coincided with
increased mRNA levels of ADAMTS 4 and 5 and aggrecanases that degrade cartilage
(Kayal et al., 2007). The accelerated loss of cartilage may be physiologically significant,
since it may leave a reduced template for endochondral bone formation. This may explain a
decrease in callus size and a decrease in the strength of healing bone that is typically found
in diabetic fracture healing (Funk et al., 2000; Beam et al., 2002). It is striking that the more
rapid removal of cartilage, greater osteoclast formation, and enhanced expression of pro-
inflammatory cytokines are the opposite of that observed in TNF receptor-deficient mice
(Gerstenfeld et al., 2003a). Thus, in diabetes, high levels of TNF-α and other pro-
inflammatory cytokines may increase osteoclastogenesis, which leads to excessive removal
of cartilage, which in turn may interfere with the transition from cartilage to bone and impair
fracture healing. In contrast, TNF receptor-deficient mice exhibit delayed osteoclast
formation, failure to remove cartilage in timely fashion, and a longer time required for
healing of fractured bone.
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The Role of the Transforming Growth Factor Beta Superfamily in Fracture Repair
The transforming growth factor-beta (TGF-β) superfamily consists of a large number of
growth and differentiation factors that include bone morphogenetic proteins (BMPs),
transforming growth factor beta (TGF-β), growth differentiation factors (GDFs), activins,
inhibins, and Müllerian inhibiting substance. Specific members of this family—such as
BMPs (2-8), GDF (1, 5, 8, and 10), and TGF-β1-3—promote various stages of
intramembranous and endochondral bone ossification during fracture healing (Cho et al.,
2002).
Bone Morphogenetic Proteins—During fracture repair, BMPs are produced by
mesenchymal cells, osteoblasts, and chondrocytes. Different BMPs function independently
of or in collaboration with each other, as well as with other members of the TGF-β
superfamily, to trigger a cascade of events that promote the formation of cartilage and bone.
Cellular processes stimulated include chemotaxis, mesenchymal cell proliferation and
differentiation, angiogenesis, and synthesis of extracellular matrix (Sakou, 1998; Reddi,
2001). Although different BMPs are closely related structurally and functionally, they
exhibit different temporal patterns of expression at different stages of fracture healing, based
on several animal experiments. In studies of murine fracture healing, BMP-2 mRNA
expression showed maximal levels within 24 hrs of injury, suggesting that this BMP plays a
role in initiating the repair cascade. Consistent with this finding are recent studies showing
that BMP-2 is necessary for post-natal bone repair and is genetically associated with the
maintenance of normal bone mass (Tsuji et al., 2006; Xiong et al., 2006). In contrast,
BMP-2 is apparently not needed for embryological bone formation (Tsuji et al., 2006; Xiong
et al., 2006). Other in vitro studies examining marrow stromal stem cell differentiation have
shown that BMP-2 controls the expression of several other BMPs, and when its activity is
blocked, marrow stromal stem cells fail to differentiate into osteoblasts (Edgar et al., 2007).
BMP- 3, -4, -7, and -8 show a restricted period of expression during fracture healing (days
14 through 21), when the resorption of calcified cartilage and osteoblastic recruitment are
most active, and coupled bone formation takes place. BMP-5 and -6 and other members of
the TGF-β superfamily are constitutively expressed from days 3-21 during fracture in mice,
suggesting that they have a regulatory effect on both intramembranous and endochondral
ossification (Cho et al., 2002).
It has been proposed that BMP-2, -6, and -9 may be the most potent inducers of
mesenchymal cell differentiation to osteoblasts, while the remaining BMPs promote the
maturation of committed osteoblasts (Cheng et al., 2003). BMP antagonists also play an
important role in fracture repair. It has been reported that the expression of noggin, which
blocks BMP-2, -4, and-7, is modulated during fracture healing (Yoshimura et al., 2001). The
pattern of noggin expression is similar to that of BMP-4, suggesting that the noggin/BMP-4
balance could be an important factor in the regulation of callus formation during fracture
healing. This is supported by findings that, in the absence of noggin, there is excess bone
and cartilage formation during development, indicating that noggin plays an important role
in limiting the formation of these tissues (Brunet et al., 1998).
Transforming Growth Factor Beta—All three isoforms of this group of morphogens
are involved in fracture repair (TGF-β1-3). They are produced by degranulated platelets
after initial injury, which suggests their involvement in the initiation of callus formation
(Bolander, 1992; Bostrom, 1998). They are also produced by osteoblasts and chondrocytes
at later stages, which enhances the proliferation of these cells as well as that of
mesenchymal cells and pre-osteoblasts (Lieberman et al., 2002). TGF-β is thought to play an
important role in chondrogenesis and endochondral bone formation (Barnes et al., 1999). It
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induces the expression of extracellular matrix proteins (Sandberg et al., 1993). The
expression of TGF-β2 and TGF-β3 peaks on day 7 post-fracture in the mouse, when type II
collagen expression rises, and appears to be associated with cartilage formation. The
expression of TGF-β1 remains constant throughout the fracture-healing process. This
suggests that TGF-β2 and TGF-β3 may play a more important role during fracture healing,
since their expression peaks during the critical phase of chondrogenesis (Cho et al., 2002).
The Role of Angiogenic Factors in Fracture Repair
Optimal bone healing is dependent on adequate vascularization and therefore requires the
development of new blood vessels. During endochondral fracture healing, the transition
from a cartilaginous callus to new bone formation represents a crucial stage in the repair
process. This stage includes four coordinated biological events: chondrocyte apoptosis;
cartilaginous matrix degradation and removal; vascularization of the repair site; and
osteogenic cell recruitment, differentiation, and bone matrix production. Disruption of any
one of these can lead to delayed or impaired healing (Vu et al., 1998; Gerber et al., 1999;
Aizawa et al., 2001; Colnot et al., 2003). In other biological processes, such as growth plate
development, disruption of any of these events has been shown to interfere with the
formation of skeletal bone. For example, disruption of cartilaginous matrix degradation
through the loss of MMP-9 expression leads to a massive expansion of the hypertrophic
zone (Vu et al., 1998), a consequence of abnormal regulation of the apoptotic process.
Moreover, in mmp-9-/- mice, a delay is observed in the progression of fracture repair, and
this effect can be rescued by the addition of exogenous VEGF (Colnot et al., 2003),
suggesting that angiogenesis is linked to the apoptosis of chondrocytes.
The above observations have led to the suggestion that the molecular regulation of
angiogenesis is linked with the removal of cartilage during endochondral bone formation.
The interdependence of the various biologic processes in fracture healing was clearly
demonstrated in data from our laboratory, which showed that lack of TNF-α signaling delays
chondrocyte apoptosis, which then leads to delays in the resorption of mineralized cartilage
and, ultimately, a delay in fracture healing (Gerstenfeld et al., 2003a; Lehmann et al., 2005).
Angiogenesis is regulated by 2 pathways, a vascular endothelial growth factor (VEGF)-
dependent pathway and an angiopoietin-dependent pathway (Suri et al., 1996). Both
pathways are speculated to be functional during fracture repair. The VEGF-related family of
proteins includes endothelial cell mitogens and essential mediators of neo-angiogenesis
(Ferrara and Davis-Smyth, 1997). It has been demonstrated that VEGF signaling plays a
central role in neo-angiogenesis and in endochondral bone formation (Gerber et al., 1999;
Street et al., 2002). Furthermore, fracture repair is enhanced by exogenous VEGF (Gerber et
al., 1999; Street et al., 2002). Osteoblasts are known to express elevated amounts of VEGF,
and therefore have been implicated as primary regulators of angiogenesis in fracture healing.
Moreover, several studies have shown that BMPs stimulate the expression of VEGF and
their receptors, suggesting an intimate relationship between these two families that promotes
the formation of new bone (Yeh and Lee, 1999; Deckers et al., 2002).
A second pathway that regulates vascular growth includes angiopoietin-1 and -2 and their
receptors. Angiopoietins are vascular morphogenetic proteins that are associated with the
formation of larger vessels and the development of collateral branches from existing vessels.
The role of angiopoietin in fracture repair is not as well-understood as the VEGF pathway.
The expression of angiopoietin-1 is induced during the initial stages of fracture repair,
suggesting that initial vascular in-growth from vessels in the periosteum plays an important
role in the repair process (Lehmann et al., 2005).
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In our studies of fracture healing, comparison of the expression profiles of angiogenic
regulators demonstrated that the most prevalent factors expressed over the time-course of
repair are angiopoietin-2, pigment epithelial-derived factor, pleiotrophin, Tie1, and vascular
endothelial growth inhibitor (Gerstenfeld et al., 2003b). The VEGF gene family members
detectable during fracture healing are VEGF-D, VEGF-A, and VEGF-C. They are expressed
throughout the chondrogenic phase of healing, reaching maximal levels of expression during
the late phases of calcification of the cartilage tissues, at the time when resorption is
initiated. A relationship between the expression of some angiogenic factors and pro-
inflammatory cytokines has been shown in mice lacking TNF receptors. The absence of
TNF receptor signaling diminishes the expression of angiopoietins, metalloproteinases, and
vascular endothelial growth inhibitor during fracture healing. However, the expression of
VEGF family members that directly promote new vessel formation is not inhibited. Taken
together, the results from this study suggest that, after injury, existent vessels are first
dissociated into a pool of non-dividing endothelial cells through the actions of
angiopoietin-2 and vascular endothelial growth inhibitor, the latter limiting proliferation. At
the time when cartilage resorption and primary bone remodeling are initiated, VEGF levels
rise, stimulating cell division of this pool of progenitors and promoting participation of these
endothelial cells in neo-angiogenesis. These results suggest that TNF-α signaling in
chondrocytes controls vascularization of cartilage through the regulation of angiopoietin and
vascular endothelial growth inhibitor factor, which play counterbalancing roles in the
induction of growth arrest and apoptosis of endothelial cells.
A third, more distantly related, member of the angiogenic signaling system is the platelet-
derived growth factor (PDGF) family. PDGF consists of a group of factors that structurally
belong to the larger family of angiogenic factors that include VEGF and placental growth
factor (Heldin and Westermark, 1999). The PDGFs are secreted from the alpha granules of
platelets as well as endothelial cells, vascular smooth-muscle cells, and macrophages
(Meyer-Ingold and Eichner, 1995). There are multiple forms of PDGF (PDGF-A, -B, -C,
and −D), which form hetero- and homodimers that are biologically active. The forms of
PDGF found in human platelets—PDGF-AA, PDGF-AB, and PDGF-BB—bind to PDGF
receptors alpha and beta. The target cells for PDGF are primarily mesenchymal cells and
include dermal fibroblasts and smooth-muscle cells. These cell types express higher levels
of PDGF ß-receptors (Heldin and Westermark, 1999).
The actions of PDGF depend on the target cell and stimulate cellular proliferation,
chemotaxis, survival, and calcium mobilization from intracellular stores (Diliberto et al.,
1992). The PDGFs also have a role in the remodeling of connective tissues through their
stimulation of collagenase (Bauer et al., 1985). Consistent with these findings, PDGF-BB
has been effectively used as a therapeutic agent to enhance dermal wound healing (Pierce et
al., 1988, 1989).
Because PDGF has been shown to enhance osteoblast migration and proliferation, and to be
secreted from osteoclasts, it has been suggested as a key factor in bone remodeling (Kubota
et al., 2002). Systemic administration of PDGF in ovariectomized rats results in increased
bone density and strength (Mitlak et al., 1996). PDGF enhances formation of a mineralizing
matrix in vitro (Hsieh and Graves, 1998) and enhances bone formation in periodontal
regeneration in vivo (Sarment et al., 2006). Exogenous PDGF enhances callus density and
bone formation associated with healing osteotomies (Nash et al., 1994). PDGF can be
detected in the callus tissue obtained from healing fractures during bone formation (Andrew
et al., 1995). It has been suggested that PDGF is an essential component of normal fracture
healing in experimental animal models (Fujii et al., 1999). In contrast, PDGF—along with
TGF-β, fibroblast growth factor-β, BMP-2, and BMP-14 expression—is lacking in fractures
that do not heal properly (Brownlow et al., 2001).
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Distraction Osteogenesis
Distraction osteogenesis (DO) is a bone-regenerative process in which osteotomy followed
by gradual distraction yields two vascularized bone surfaces, from which new bone is
formed. First described by Codivilla (1905) for the treatment of limb length discrepancies, it
was not until the work of Ilizarov (1989), more than 50 years later, that the technique of DO
gained widespread clinical use as a method for enhancing bone regeneration in clinical
orthopedics and oral/maxillofacial surgery (Aronson, 1994b). The cellular and molecular
processes of distraction osteogenesis are summarized in Tables 3 and 4.
Three modes of ossification take place during DO. Although endochondral ossification
occurs during early stages of DO, intramembranous bone formation is the predominant
mechanism of ossification, particularly in later stages. A third form of ossification, called
‘transchondroid bone formation’, has been suggested to occur. During transchondroid
ossification, chondroid bone is formed directly by chondrocyte-like cells, with transition
from fibrous tissue to bone occurring gradually (Yasui et al., 1997; Choi et al., 2002).
Cartilage that forms during DO is usually observed at the level of the periosteum, but not
between the ends of the cortices within the distraction gap.
Distraction osteogenesis can be divided into three temporal and dynamic phases: latency,
distraction, and consolidation. The latency phase allows for the initial trauma response to
take place. It starts immediately following creation of the osteotomy and extends until the
onset of active distraction. Events taking place during this phase are basically the same as
those in the early stages of fracture repair. However, by the time the active distraction phase
has been initiated, the primary inflammatory processes have been completed. During the
distraction phase, tensile forces are applied to the callus with a specific rate and rhythm. As
the callus is stretched, a central fibrous zone, called the fibrous interzone (FIZ), forms. It is
rich in chondrocyte-like cells, fibroblasts, and oval cells, which are morphologically
intermediate between fibroblasts and chondrocytes (Vauhkonen et al., 1990; Aronson,
1994b; Sato et al., 1998). The differentiating osteoblasts at the fibrous interzone deposit
osteoid along collagen bundles. They subsequently undergo mineral crystallization parallel
to the collagen bundles, forming a zone called the ‘zone of microcolumn formation’ (MCF).
In between the fibrous interzone and microcolumn formation, a zone of highly proliferating
cells, called the ‘primary matrix’ or ‘mineralization front’ (PMF), is observed (Aronson et
al., 1990). Once the desired bone length is achieved, distraction ceases, marking the
beginning of the consolidation phase, where bone and extensive amounts of osteoid undergo
mineralization and eventual remodeling.
Bone regeneration during distraction osteogenesis is believed to occur in response to the
longitudinal mechanical strain applied to the callus during healing. The exact mechanism by
which strain stimulates bone formation remains unclear. It has been suggested that living
tissues become metabolically activated by slow, steady traction, a phenomenon called
‘mechano-transduction’, characterized by the stimulation of proliferative and biosynthetic
cellular functions (Ilizarov, 1989). Also, recent molecular investigations have indicated that
the molecular signaling cascade plays an important role in the relationship between induced
strain and bone regeneration. Although distraction regenerates the bone tissues by a process
very different from that of fracture repair, the molecular signals that drive the regenerative
process are similar and include the pro-inflammatory cytokines, the transforming growth
factor beta superfamily, and angiogenic factors.
The Role of Pro-inflammatory Cytokines in Distraction Osteogenesis
Just like fracture, the expression of pro-inflammatory cytokines IL-1 and IL-6 is up-
regulated after osteotomy and then returns to baseline levels rapidly during the latency
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period. However, the expression of IL-6 is elevated a second time, once distraction is started
and mechanical strain is applied to the callus. During the distraction phase, IL-6 is expressed
by the oval cells residing in the fibrous interzone, the zone at which tensile strains are the
highest, as well as by osteoblasts and chondrocytes. Therefore, IL-6 released in response to
stress has been hypothesized to contribute to intramembranous ossification, by enhancing
the differentiation of cells committed to the osteoblastic linage (Cho et al., 2007).
It has been reported that the expression of TNF-α remains silent throughout the distraction
osteogenesis process, suggesting that its expression is induced only by a more substantial
trauma (Cho et al., 2007). However, studies conducted in our laboratories reached a
different conclusion when the temporal patterns of expression of TNF-α superfamily
members were examined. During distraction osteogenesis in mouse tibiae, TNF-α mRNA
levels markedly increased toward the end of consolidation (unpublished data). In addition,
the RANKL/OPG expression ratio increased at the beginning of the distraction phase, and
decreased by the end of consolidation. These results are similar to those from another study
conducted on mandibular distraction osteogenesis (Wang et al., 2005). A comparison of
these results suggests that the resorption of mineralized cartilage in the external callus areas
that form adjacent to the ends of the bone tissues and in the gap during the latency phase of
distraction osteogenesis is more dependent on the levels of RANKL and OPG and less
affected by other cytokines (Gerstenfeld et al., 2003a). In contrast, cartilage removal and
bone remodeling in fracture healing are more dependent on the activity of TNF-α
(Gerstenfeld et al., 2003a).
The Role of the Transforming Growth Factor Beta Superfamily in Distraction Osteogenesis
Bone Morphogenetic Proteins—Different BMPs exhibit different temporal patterns of
expression during distraction osteogenesis. The expression of BMP-2 and BMP-4 rises in
the early latency phase, probably to accelerate the differentiation of precursor cells into
chondrogenic/osteogenic cells. The expression of BMP-2 and -4 is strongly enhanced by the
application of mechanical strain during the distraction phase. They are produced by
chondrogenic cells involved in cartilage formation and osteogenic cells at the primary
mineralizing front. Also, they are produced by the oval cells residing in the fibrous
interzone, which may form bone in response to strain (Lammens et al., 1998; Li et al., 1998;
Liu et al., 1999; Sato et al., 1999; Rauch et al., 2000; Farhadieh et al., 2004). Once
distraction has stopped, the expression of BMP-2 and BMP-4 gradually disappears (Sato et
al., 1999; Rauch et al., 2000; Marukawa et al., 2006). It has been reported that the
expression of these BMPs could last for up to two weeks after the cessation of distraction,
implying that they play a role in the proliferation of cells required for the completion of
bone healing (Yazawa et al., 2003; Marukawa et al., 2006). Since BMP-2 has osteo-
inductive properties, the administration of exogenous BMP-2 has been used successfully to
shorten the treatment time during distraction osteogenesis by accelerating bone formation
during the consolidation stage (Yonezawa et al., 2006). BMP-6, in contrast, peaks during the
late phase of latency and the early phase of distraction. It then declines toward the late
distraction phase, as the mode of ossification transforms from endochondral to
intramembranous, reflecting its role in the endochondral phase (Li et al., 1998; Sato et al.,
1999; Rauch et al., 2000). It has been reported that BMP-7 plays a role similar to that of
BMP-2 and BMP-4 in distraction osteogenesis (Rauch et al., 2000); however, most
experiments have detected only weak levels or no expression of BMP-7 during distraction
osteogenesis (Sato et al., 1999; Campisi et al., 2003; Yazawa et al., 2003).
Transforming Growth Factor Beta—Toward the end of latency, TGF-β displays an
increased level of expression that lasts into the distraction phase. It displays diffuse
expression throughout the distraction gap (Liu et al., 1999). An inverse relationship between
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TGF-β and osteocalcin has been observed in a canine distraction model, where elevated
TGF-β levels were accompanied by lower levels of osteocalcin after the initiation of
distraction osteogenesis (Lammens et al., 1998). These observations suggest that TGF-β
suppresses osteoblast maturation by delaying differentiation of osteoblasts during the
mineralization stage of distraction osteogenesis.
Other Morphogens and Growth Factors—Insulin-like growth factor 1 (IGF-1) and
basic fibroblast growth factor (bFGF) are also induced during distraction. Basic fibroblast
growth factor is mainly expressed by cells of osteoblastic lineage and mesenchymal cells on
the newly formed trabecular bone (Farhadieh et al., 1999). Insulin-like growth factor-1, in
contrast, is diffusely expressed throughout the distraction gap (Liu et al., 1999). Once
distraction has ceased, the expression of insulin-like growth factor-1 returns to basal levels,
whereas basic fibroblast growth factor drops to levels lower than those observed during
distraction, although some osteoblasts continue to express it during consolidation (Liu et al.,
1999; Yeung et al., 2001).
The Role of Angiogenic Factors in Distraction Osteogenesis
Similar to fracture healing, distraction osteogenesis increases the demand on the surrounding
tissues to increase blood flow, so that successful induction of new bony regeneration can
occur (Aronson, 1994a; Carvalho et al., 2004). Neo-angiogenesis during distraction
osteogenesis may be induced by VEGF-A and neuropilin, an alternative receptor for VEGF.
During distraction osteogenesis, the expression of other VEGF ligands and receptors is
many-fold less than that of VEGF-A and neuropilin1 and is difficult to quantify. The one
exception is VEGF-D, which peaks at the end of the latency period and in early periods of
active distraction, but shows diminished expression at later stages (Carvalho et al., 2004).
The expression of VEGF-A is primarily localized to maturing osteoblasts at the primary
mineralizing front and to osteoclasts located at the zone of microcolumn formation (Choi et
al., 2002). The localization of VEGF-A to the primary mineralizing front suggests that there
is a tight spatial coordination between areas of neovascularization and new bone formation
(Pacicca et al., 2003).
Another family of angiogenic factors, the angiopoietins, is also expressed during distraction.
The temporal appearance of angiopoietin-1 is followed by angiopoietin-2, which in turn is
followed by a maximal expression of VEGF-A in the distraction model. Angiopoietin-2 by
itself is antagonistic to angiopoietin-1. However, it has been proposed that the combination
of angiopoieten-2 and VEGF-A stimulates new vessel formation, enhances the plasticity of
existent larger vessels, and contributes to new vessel formation (Pacicca et al., 2003). It has
also been reported that the increase in VEGF-A and angiopoietin-1 expression is associated
with an up-regulation in the expression of hypoxia-induced factor 1 alpha (Hif1α), which is
one of the key transcription factors regulating genes associated with an angiogenic response,
such as VEGF-A and angiopoietin-1 (Pacicca et al., 2003; Carvalho et al., 2004).
Differences between Fracture Repair and Distraction Osteogenesis
Although bone regeneration during distraction osteogenesis uses many of the same basic
processes involved in healing fractures, there are also unique cellular and molecular aspects
to this form of tissue repair. The most striking differences are illustrated when one contrasts
the histological and computerized tomographic sections of fracture calluses and distraction
osteogenesis (Figs. 1, 2). These comparisons show both differences in temporal processes of
healing and bone formation and variations in the spatial localization of the bone tissue
formed.
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The regenerative processes of distraction osteogenesis and fracture healing are both
characterized by intramembranous and endochondral bone formation. However,
endochondral bone formation is considered the predominant form of ossification during
fracture repair, whereas intramembranous ossification dominates over endochondral bone
formation during distraction osteogenesis (Yasui et al., 1997; Einhorn, 1998). Differences in
the timing of these two types of bone formation processes and spatial differences in where
these processes occur can be noted in Figs. 1 and 2. In the case of fracture healing,
endochondral bone formation robustly occurs in the first week after fracture and leads to a
substantial volume of tissue formed outside the bone in the periosteal space. In contrast,
much less cartilage is formed and is restricted to the early periods after distraction is
initiated, after which it is rapidly resorbed. Other features worth noting are the large
amounts of unmineralized osteoid in the central region of the distraction gap, whereas, at
comparable times after injury, endochondral bone in the fracture callus has calcified and is
undergoing the first round of primary bone formation (compare days 17 and 20 DO with day
21 fracture; Figs. 1, 2). One last feature to note is the primary difference in timing of the
initiation of angiogenesis. In fracture healing, these processes are initiated in the period
between days 7 and 14, as the chondrogenic tissues undergo apoptosis and resorption. In
contrast, during distraction, these processes are initiated only after active distraction has
begun, and are believed to be driven by the actual distraction processes, and not by signals
elaborated by the development of chondrogenesis. This conclusion is supported by the
observation that development of the majority of the new blood vessels occurs in the
medullary space (Pacicca et al., 2003; Jacobsen et al., 2005) of the distraction regenerate. In
contrast, the majority of vessels in fracture healing form in the external callus and are
associated with the transition from cartilage to bone (Duvall et al., 2007).
Differences between fracture healing and distraction osteogenesis are seen at the level of
molecular signaling. During fracture repair, the levels of IL-1, IL-6, and TNF-α are elevated
within the first 24 hrs after injury, then decline below their basal levels during the
endochondral phase. They then return to their basal levels during the remodeling stage. In
contrast, during distraction osteogenesis, only IL-1 and IL-6 display elevated expression in
response to initial injury, whereas TNF-α is increased significantly less. This may be due to
the fact that injury associated with osteotomy in distraction osteogenesis is not as profound
as the trauma associated with a fracture, and there is less chondroid tissue resorption. In
addition, IL-6 levels are elevated in response to mechanical strain, suggesting that this
cytokine has an anabolic effect during distraction osteogenesis, rather than a catabolic effect,
as is observed during fracture repair (Cho et al., 2007). The enhanced bone formation
observed during distraction osteogenesis may be mediated by the collaborative induction of
BMP-2 and -4 expression during the distraction phase, since BMP-2 expression is restricted
to the inflammatory phase of fracture repair, whereas BMP-4 is induced during the phases of
both endochondral and primary bone formation (Sato et al., 1999; Cho et al., 2002).
An optimal angiogenic response has been shown to be directly related to the rate of
distraction. Numerous investigators have speculated that it is this characteristic that drives
bone formation, through an intramembranous pathway (Lewinson et al., 2001; Meyer et al.,
2001). It should be noted that while both fracture repair and bone formation during
distraction osteogenesis require increased blood flow, greater vascularization is observed
during distraction osteogenesis compared with fracture healing (Aronson et al., 1990).
During both fracture repair and distraction osteogenesis, the same angiogenic factors
directly regulate vessel formation. While all four forms of VEGF expression are seen in
distraction osteogenesis and fracture healing, the expression of VEGFs, compared with that
of the angiopoietins and Tie receptors, is lower in distraction osteogenesis. In contrast,
during fracture healing, the expression patterns are reversed, so that the expression of
VEGFs is higher than that of angiopoietins and Tie receptors. It is also interesting to note
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that while angiopoietin-1 is expressed at fairly high levels in distraction osteogenesis, it is
expressed to a lesser degree than angiopoietin-2 in the fracture calluses. These observations
suggest that while the stabilization and growth of existing vessels in the endosteal space
provide initial vascularization of the distraction gap, the vascularization during fracture
healing is driven by new vessel formation within the periosteum (Jazrawi et al., 1998; Claes
et al., 2002). Other interesting differences to note include the very high levels of
pleiotrophin (Ptn), TGF-β2, fibroblast growth factor receptor-4, and the higher levels of
VEGF-D, in comparison with levels of other VEGFs, in distraction osteogenesis relative to
those levels seen in fractures. Although not as extensively examined in distraction as in
fracture healing, platelet-derived growth factor expression has also been shown in
distraction tissues and in cells found within distraction regenerates. Platelet-derived growth
factor and basic fibroblast growth factor are observed adjacent to areas of new vessel
formation (Knabe et al., 2005).
Our own studies have shown that the regulation of angiogenesis in distraction tissues is
associated with much higher levels of hypoxia-inducible factor 1α, all of the
thrombospondins, and tenascin, compared with fracture calluses (Pacicca et al., 2003). In
this regard, the transient up-regulation of hypoxia-inducible factor 1α in response to each
round of distraction would suggest that many of the downstream genes that are targets of
transcriptional activation of hypoxia-inducible factor 1α, such as VEGF-A, may play a
major role in promoting new bone formation during distraction osteogenesis. Studies
examining the role of VEGF activity in distraction osteogenesis by inhibiting both receptors
VEGF receptor-1 (Flt-1) and VEGF receptor-2 (Flk-1), or only VEGF receptor-2, with
selective antibody blockade showed that both angiogenesis and osteogenesis in distraction
osteogenesis were dependent on the activity of both VEGF receptors 1 and 2 (Jacobsen et
al., 2005). In contrast, studies of fracture healing in which VEGF activity was inhibited led
to delayed healing and a failure to progress from a cartilaginous to a bony callus (Street et
al., 2002). The basic differences were that while bone healing almost totally fails in the
absence of angiogenesis in distraction osteogenesis, the formation of cartilage occurs but
fails to progress to bone formation when angiogenesis is inhibited. This further differentiates
the role of angiogenesis in intramembranous and endochondral bone formation.
In summary, fracture healing and distraction osteogenesis are driven by the activities of
molecular mediators of inflammation, the TGF-β superfamily of morphogens, and mediators
of angiogenesis. The primary differences between the two processes of new bone formation
are in the relative levels of expression of individual mediators and their timing of
expression.
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Abbreviations
TGF tumor-derived growth factor
BMP bone morphogenetic protein
TNF tumor necrosis factor
IL interleukin
RANKL receptor activator of nuclear factor-kappaB ligand
Rank receptor activator of nuclear factor-kappaB receptor
OPG osteoprotegerin
M-CSF macrophage colony-stimulating factor
VEGF vascular endothelial growth factor
VEGFR vascular endothelial growth factor receptor
VEGI vascular endothelial growth inhibitor
Ang angiopoietin
PDGF platelet-derived growth factor
IGF insulin-derived growth factor
FGF fibroblast-derived growth factor
PEDF pigment epithelium-derived factor
Nrp neuropilin
All other abbreviations and acronyms are denoted in the text.
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Figure 1.
Comparisons of the tissue histology and mineralized tissue structure of fracture callus and
distraction gap tissues. Murine femur fracture calluses and tibia distraction gap tissue were
prepared from specimens obtained 21 days post-fracture or at 21 days post-surgery. (Panel
A) Representative longitudinal sections of fracture and distraction osteogenesis were stained
with Safranin-O/fast green. Original magnification 25×. (Panel B) Representative
longitudinal microCT images at a resolution of 12 microns. Arrows indicate the extent of
new bone formation. Both sets of images are presented with the distal and proximal
orientations, left to right. The various zones in distraction osteogenesis are indicated. The
central fibrous zone, histologically called the fibrous interzone (FIZ), is rich in chondrocyte-
like cells, fibroblasts, and oval cells that are morphologically intermediate between
fibroblasts and chondrocytes. The fibrous interzone contains differentiating osteoblasts that
deposit osteoid along collagen bundles. When these collagen bundles mineralize, they form
a zone called the zone of microcolumn formation (MCF). In between the fibrous interzone
and the zone of microcolumn formation is a zone of high cell density called the primary
matrix or mineralization front (PMF). Separate scale bars for both the histological and
microCT images are presented below each image (1 mm).
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Figure 2.
Comparison of the progression of healing in fractures and distraction osteogenesis. Murine
femur fracture calluses and tibia distraction gap tissues were prepared at the indicated time-
points. The different stages of healing and bone formation are given for each. Representative
histologic specimens are stained with Safranin-O/fast green, which stains cartilage bright
red. The scale bar in the lower right indicates 1 mm for all panels.
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Table 1
Summary of the Multiple Stages of Fracture Healing and the Accompanying Expression
of Signaling Molecules (based on published results from Kon et al., 2001; Cho et al.,
2002; Gerstenfeld et al., 2003b; Dimitriou et al., 2005)
Stage of Fracture Repair Biological Processes Expression of Signaling Molecules and their Proposed
Functions
Inflammation Hematoma IL-1, IL-6, and TNF-α play a role in initiating the repair cascade.
Inflammation TGF-β, PDGF, and BMP-2 expression increases to initiate callus
formation.
Recruitment of mesenchymal stem
cells






TGF-β2, -β3, and GDF-5 peak due to their involvement in
chondrogenesis and endochondral bone formation.
Cell proliferation in intramembranous
ossification
BMP-5 and -6 rise.
Vascular in-growth Angiopoietins and VEGFs are induced to stimulate vascular in




Phase of most active osteogenesis TNF-α rises in association with mineralized cartilage resorption.
This promotes the recruitment of mesenchymal stem cells and
induces apoptosis of hypertrophic chondrocytes.
Bone cell recruitment and woven
bone formation
RANKL and MCSF rise in association with mineralized cartilage
resorption.
Chondrocyte apoptosis and matrix
proteolysis
Osteoclast recruitment and cartilage
resorption
BMP-3, -4, -7, and -8 rise in association with the resorption of
calcified cartilage. They promote recruitment of cells in the
osteoblastic lineage.
Neo-angiogenesis BMP-5 and -6 remain high during this stage, suggesting a
regulatory effect on both intramembranous and endochondral
ossification.
VEGFs are up-regulated to stimulate neo-angiogenesis.
Secondary Bone Formation and
Remodeling
Bone remodeling coupled with
osteoblast activity
IL-1 and IL-6 rise again in association with bone remodeling,
whereas RANKL and MCSF display diminished levels.
Establishment of marrow Diminished expression of members of the TGF-β superfamily.
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Table 2
Summary of the Stages* of Fracture Repair and Their Associated Molecular Regulators








 IL-1 ↑↑↑ ↑↑
 IL-6 ↑↑↑
 TNF-α ↑↑↑ ↑↑ ↑↑
 RANKL ↑↑↑ ↑↑↑ ↑↑
 OPG ↑↑↑ ↑↑↑
 MCSF ↑↑↑ ↑↑↑
TGF-β Superfamily
 BMP-2 ↑↑↑ ↑↑↑ ↑↑↑ ↑↑↑
 BMP-3 ↑ ↑↑↑ ↑
 BMP-4 ↑ ↑↑↑ ↑↑↑ ↑
 BMP-5 ↑ ↑↑↑ ↑↑↑ ↑
 BMP-6 ↑ ↑↑↑ ↑↑↑ ↑
 BMP-7 ↑↑↑
 BMP-8 ↑↑↑
 TGF- 2 ↑↑↑
 TGF- 3 ↑↑↑ ↑↑
 GDF-5 ↑↑↑
 GDF-8 ↑↑↑
 GDF-10 ↑↑↑ ↑↑↑ ↑↑↑
Angiogenic Factors
 VEGF A ↑ ↑↑
 VEGF B ↑↑
 VEGF C ↑↑
 VEGF D ↑↑ ↑
 Angiopoietin 1 ↑↑ ↑↑ ↑ ↑
 Angiopoietin 2 ↑ ↑ ↑ ↑
*
The different stages of the fracture-healing process are separated by dashed lines, since they overlap. The relative expressions of the different
signaling molecules are denoted by arrows, indicating intensity of expression. Based on published results from Kon et al., 2001; Cho et al., 2002;
Gerstenfeld et al., 2003b; Lehmann et al., 2005; Dimitriou et al., 2005.
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Table 3
Summary of the Biological Processes Taking Place during Multiple Stages of Distraction
Osteogenesis and the Associated Expression of Signaling Molecules (based on published




Biological Processes Expression of Signaling Molecules and their Proposed Functions
Latency Hematoma
Inflammation
Recruitment of mesenchymal stem cells
Periosteal callus and cartilage formation
IL-1 and IL-6 are up-regulated after osteotomy, then return to baseline.
BMP-2 and BMP-4 rise during the early latency phase to accelerate
differentiation of precursor cells into chondrogenic/osteogenic cells.
RANKL/OPG ratio increases by the late latency phase in association with
cartilage resorption.
BMP-6 and TGF-β expression rise during the late latency phase, due to the
role they play in endochondral ossification.
Active Distraction The callus is stretched.
Cartilage resorption and endochondral
bone formation.
Formation of a central fibrous interzone
comprised of fibroblast cells and collagen
fibers aligned parallel to the vector of
elongation.
Neo-angiogenesis between collagen fiber
bundles.
Osteoblast recruitment and arrangement
along the new vessels, followed by
intramembranous ossification and bone
column formation.
IL-6 rises again during this phase to contribute to intramembranous
ossification by enhancing the differentiation of cells committed to the
osteoblastic lineage.
RANKL/OPG ratio remains high during the early distraction phase to
promote resorption of the remaining mineralized cartilage formed during
the latency phase.
BMP-6 expression remains high during the early distraction phase.
BMP-2, BMP-4, and TGF-β expression peak during this phase to stimulate
uninterrupted bone formation in response to strain caused by distraction.
IGF-1 and bFGF are induced during this phase.
VEGF and angiopoietin-1 and -2 are up-regulated to stimulate new vessel
formation and enhance the plasticity of existent larger vessels.
Consolidation Bone columns interconnect.
Osteoclast recruitment.
Remodeling.
BMP-2, BMP-4, and bFGF expression gradually disappears.
TNF-α markedly increases toward the end of the consolidation phase,
suggesting that it regulates bone remodeling.
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